The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

KU ASCO 2019 Non Hodgkin Lymphoma Update : Polatuzumab Vedotin for R/R DLBCL, Chemo for Waldenstroms, Lenalidomide and Rituximab in Relapsed Indolent Lymphoma, & Induction Rituximab in iNHL

461 views
August 19, 2019
Comments 0
Login to view comments. Click here to Login